155 related articles for article (PubMed ID: 21637745)
21. Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2070-7. PubMed ID: 18708400
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
Amankwah EK; Kelemen LE; Wang Q; Song H; Chenevix-Trench G; ; Beesley J; Webb PM; ; Pearce CL; Wu AH; Pike MC; Stram DO; Chang-Claude J; Wang-Gohrke S; Ness RB; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Tworoger SS; Whittemore AS; McGuire V; Sieh W; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Rossing MA; Doherty JA; Goodman MT; Carney ME; Lurie G; Wilkens LR; Kjær SK; Høgdall E; Cramer DW; Terry KL; Garcia-Closas M; Yang H; Lissowska J; Anton-Culver H; Ziogas A; Schildkraut JM; Berchuck A; Pharoah PD;
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1028-31. PubMed ID: 21415361
[TBL] [Abstract][Full Text] [Related]
23. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).
Bolton KL; Ganda C; Berchuck A; Pharaoh PD; Gayther SA
J Intern Med; 2012 Apr; 271(4):366-78. PubMed ID: 22443200
[TBL] [Abstract][Full Text] [Related]
24. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Permuth-Wey J; Lawrenson K; Shen HC; Velkova A; Tyrer JP; Chen Z; Lin HY; Chen YA; Tsai YY; Qu X; Ramus SJ; Karevan R; Lee J; Lee N; Larson MC; Aben KK; Anton-Culver H; Antonenkova N; Antoniou AC; Armasu SM; ; ; Bacot F; Baglietto L; Bandera EV; Barnholtz-Sloan J; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Cai Q; Campbell I; Chang-Claude J; Chanock S; Chenevix-Trench G; Cheng JQ; Cicek MS; Coetzee GA; ; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; du Bois A; Dürst M; Easton DF; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher DA; Flanagan JM; Garcia-Closas M; Gentry-Maharaj A; Giles GG; Glasspool RM; Gonzalez-Bosquet J; Goodman MT; Gore M; Górski B; Gronwald J; Hall P; Halle MK; Harter P; Heitz F; Hillemanns P; Hoatlin M; Høgdall CK; Høgdall E; Hosono S; Jakubowska A; Jensen A; Jim H; Kalli KR; Karlan BY; Kaye SB; Kelemen LE; Kiemeney LA; Kikkawa F; Konecny GE; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Lancaster JM; Le ND; Leminen A; Levine DA; Liang D; Lim BK; Lin J; Lissowska J; Lu KH; Lubiński J; Lurie G; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Menon U; Modugno F; Moysich KB; Nakanishi T; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Noushmehr H; Odunsi K; Olson SH; Orlow I; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Raska P; Renner SP; Risch HA; Rodriguez-Rodriguez L; Rossing MA; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schwaab I; Severi G; Shridhar V; Shu XO; Shvetsov YB; Sieh W; Song H; Southey MC; Spiewankiewicz B; Stram D; Sutphen R; Teo SH; Terry KL; Tessier DC; Thompson PJ; Tworoger SS; van Altena AM; Vergote I; Vierkant RA; Vincent D; Vitonis AF; Wang-Gohrke S; Palmieri Weber R; Wentzensen N; Whittemore AS; Wik E; Wilkens LR; Winterhoff B; Woo YL; Wu AH; Xiang YB; Yang HP; Zheng W; Ziogas A; Zulkifli F; Phelan CM; Iversen E; Schildkraut JM; Berchuck A; Fridley BL; Goode EL; Pharoah PD; Monteiro AN; Sellers TA; Gayther SA
Nat Commun; 2013; 4():1627. PubMed ID: 23535648
[TBL] [Abstract][Full Text] [Related]
25. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PD; Webb PM; Chenevix-Trench G; ; ;
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2557-65. PubMed ID: 18086758
[TBL] [Abstract][Full Text] [Related]
26. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
[TBL] [Abstract][Full Text] [Related]
27. Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.
Winterhoff BJ; Maile M; Mitra AK; Sebe A; Bazzaro M; Geller MA; Abrahante JE; Klein M; Hellweg R; Mullany SA; Beckman K; Daniel J; Starr TK
Gynecol Oncol; 2017 Mar; 144(3):598-606. PubMed ID: 28111004
[TBL] [Abstract][Full Text] [Related]
28. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q
Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
Schildkraut JM; Goode EL; Clyde MA; Iversen ES; Moorman PG; Berchuck A; Marks JR; Lissowska J; Brinton L; Peplonska B; Cunningham JM; Vierkant RA; Rider DN; Chenevix-Trench G; Webb PM; Beesley J; Chen X; Phelan C; Sutphen R; Sellers TA; Pearce L; Wu AH; Van Den Berg D; Conti D; Elund CK; Anderson R; Goodman MT; Lurie G; Carney ME; Thompson PJ; Gayther SA; Ramus SJ; Jacobs I; Krüger Kjaer S; Hogdall E; Blaakaer J; Hogdall C; Easton DF; Song H; Pharoah PD; Whittemore AS; McGuire V; Quaye L; Anton-Culver H; Ziogas A; Terry KL; Cramer DW; Hankinson SE; Tworoger SS; Calingaert B; Chanock S; Sherman M; Garcia-Closas M;
Cancer Res; 2009 Mar; 69(6):2349-57. PubMed ID: 19276375
[TBL] [Abstract][Full Text] [Related]
32. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
[TBL] [Abstract][Full Text] [Related]
33. Genetic Association of Interleukin-31 Gene Polymorphisms with Epithelial Ovarian Cancer in Chinese Population.
Liu C; Wang Y; Song H; Li Q; Zhang Y; Chen P; Song Y; Su M; Huang Q; Wang M; Zhou B; Zhang L
Dis Markers; 2018; 2018():3503858. PubMed ID: 29484036
[TBL] [Abstract][Full Text] [Related]
34. Functional polymorphisms in monocyte chemoattractant protein-1 are associated with increased susceptibility to ovarian cancer.
Wei X; Tian Y; Lu W; Li W; Zhang M; Lu X; Liu Y
DNA Cell Biol; 2015 Jan; 34(1):37-42. PubMed ID: 25289731
[TBL] [Abstract][Full Text] [Related]
35. Identification of sequence nucleotide polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for epithelial ovarian cancer.
Liu S; Shi S; Li Y; Kong D
Mitochondrial DNA A DNA Mapp Seq Anal; 2016; 27(1):9-11. PubMed ID: 24438298
[TBL] [Abstract][Full Text] [Related]
36. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
Kotsopoulos J; Vitonis AF; Terry KL; De Vivo I; Cramer DW; Hankinson SE; Tworoger SS
Cancer Causes Control; 2009 Apr; 20(3):335-44. PubMed ID: 18941913
[TBL] [Abstract][Full Text] [Related]
37. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
Notaridou M; Quaye L; Dafou D; Jones C; Song H; Høgdall E; Kjaer SK; Christensen L; Høgdall C; Blaakaer J; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Gentry-Maharaj A; Wozniak E; Sher T; Jacobs IJ; Tyrer J; Schildkraut JM; Moorman PG; Iversen ES; Jakubowska A; Mędrek K; Lubiński J; Ness RB; Moysich KB; Lurie G; Wilkens LR; Carney ME; Wang-Gohrke S; Doherty JA; Rossing MA; Beckmann MW; Thiel FC; Ekici AB; Chen X; Beesley J; ; Gronwald J; Fasching PA; Chang-Claude J; Goodman MT; Chenevix-Trench G; Berchuck A; Pearce CL; Whittemore AS; Menon U; Pharoah PD; Gayther SA; Ramus SJ;
Int J Cancer; 2011 May; 128(9):2063-74. PubMed ID: 20635389
[TBL] [Abstract][Full Text] [Related]
38. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
Kelemen LE; Goodman MT; McGuire V; Rossing MA; Webb PM; ; Köbel M; Anton-Culver H; Beesley J; Berchuck A; Brar S; Carney ME; Chang-Claude J; Chenevix-Trench G; ; Cramer DW; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Fredericksen ZS; Fridley BL; Gates MA; Gayther SA; Gentry-Maharaj A; Høgdall E; Kjaer SK; Lurie G; Menon U; Moorman PG; Moysich K; Ness RB; Palmieri RT; Pearce CL; Pharoah PD; Ramus SJ; Song H; Stram DO; Tworoger SS; Van Den Berg D; Vierkant RA; Wang-Gohrke S; Whittemore AS; Wilkens LR; Wu AH; Schildkraut JM; Sellers TA; Goode EL;
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1822-30. PubMed ID: 20570913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]